| Date Filed | Type | Description |
| 08/14/2023 |
4
| Lask Alisa (Director) has filed a Form 4 on RVL Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 12,000 shares
@ $0.49, valued at
$5.9k
|
|
| 07/11/2023 |
4
| Lask Alisa (Director) has filed a Form 4 on RVL Pharmaceuticals plc|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 01/09/2023 |
4
| Lask Alisa (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 27,613 shares
@ $0
Granted 7,080 options to buy
@ $1.07, valued at
$7.6k
|
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| Lask Alisa (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 3,227 shares
@ $0
Granted 5,568 options to buy
@ $8.57, valued at
$47.7k
|
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2019 |
4/A
| Lask Alisa (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 86,546 options to buy
@ $0.58, valued at
$50.2k
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |